1 asset in Pediatric Lymphoma
Therapeutic assets addressing Pediatric Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Iopofosine (¹³¹I) Pediatric Lymphoma | Cellectar Biosciences, Inc. | P1 | CC (43) |
Therapeutic assets addressing Pediatric Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Iopofosine (¹³¹I) Pediatric Lymphoma | Cellectar Biosciences, Inc. | P1 | CC (43) |